- Home
- /
- Treatment
- /
- Page 155
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Somatropin | Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures | Novo Nordisk Pharmaceuticals;100 Overlook Center, Suite 200;Princeton, New Jersey, 08540 | September 1, 1987 | |
CD5-T lymphocyte immunotoxin | Graft Versus Host Disease | Xoma Corporation;2910 Seventh Street;Berkeley, California, 94710 | August 27, 1987 | |
Epoetin alpha | Anemia associated with end stage renal disease | R. W. Johnson Pharmaceutical Research Institute;Route 202 South, P.O. Box 300;Raritan, New Jersey, 08869 | August 27, 1987 | |
Erythropoietin (recombinant human) | Anemia associated with end stage renal disease | McDonnell Douglas Corp;P.O. Box 516, 107/2 MS10;St. Louis, Missouri, 63166 | August 19, 1987 | |
Acetylcysteine | Intravenous treatment of patients presenting with moderate to severe acetaminophen overdose | Bristol-Myers Squibb Company;P.O. Box 4500;Princeton, New Jersey, 08543 | August 13, 1987 | |
ST1-RTA immunotoxin (SR 44163) | Acute lymphoblastic leukemia | Sanofi Winthrop, Inc.;9 Great Valley Parkway;Malvern, Pennsylvania, 19355 | August 12, 1987 | |
ST1-RTA immunotoxin (SR 44163) | Prevention of acute graft versus host disease in allogenic bone marrow transplantation | Sanofi Winthrop, Inc.;9 Great Valley Parkway;Malvern, PA, 19355 | August 12, 1987 | |
ST1-RTA immunotoxin (SR 44163) | Patients with B-chronic lymphocytic leukemia | Sanofi Winthrop, Inc.;9 Great Valley Parkway;Malvern, PA, 19355 | August 12, 1987 | |
5-aza-2′-deoxycytidine | Acute leukemia | SuperGen, Inc.;4140 Dublin Blvd., Suite 200;Dublin, California, 94568 | August 3, 1987 | |
Trisaccharides A and B | Moderate to very severe clinical forms of transfusion reactions arising from ABO incompatible transfusions of blood, blood products, and blood derivatives | Chembiomed, Ltd.;P.O. Box 8050, T6H 4NP; | August 3, 1987 | |
Interferon alfa-2b (recombinant) | Ovarian cancer | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | August 3, 1987 | |
Cytomegalovirus immune globulin (human) | Prevention or attenuation of primary cytomegalovirus disease in immunosuppressed recipients of organ transplants | CSL Behring LLC;1020 First Avenue, P. O. Box 61501;King of Prussia, Pennsylvania, 19406 | August 3, 1987 | |
Mefloquine HCl | Prevention of chloroquine-resistant Falciparum malaria | Mepha AG;4143 Dornach, POSTFASH 137; | July 22, 1987 | |
Mefloquine HCl | Chloroquine-resistant Falciparummalaria | Mepha AG;4143 Dornach, POSTFASH 137; | July 22, 1987 | |
Mefloquine HCl | Treatment and prevention of chloroquine-resistant Falciparummalaria | Mepha AG;4143 Dornach, Aesch Basel; | July 22, 1987 | |
2′-3′-dideoxyadenosine | Aquired immunodeficiency syndrome | National Cancer Institute, Dct;NIH, Exec. Plaza N., Room 7-18;Bethesda, Maryland, 20892 | July 21, 1987 | |
Mitoxantrone HCl | Acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia | Lederle Laboratories;Division of American Cyanamid Company, 401 N. Middletown Road;Pearl River, New York, 10965 | July 13, 1987 | |
Somatropin (rDNA origin) injection | Growth failure in children due to inadequate growth hormone secretion | Novo Nordisk Pharmaceuticals;100 Overlook Center, Suite 200;Princeton, NJ, 08540 | July 10, 1987 | |
Somatropin (rDNA origin) injection | SHORT syndrome | Novo Nordisk Pharmaceuticals;100 Overlook Center, Suite 200;Princeton, New Jersey, 08540 | July 10, 1987 | |
Interferon alfa-2b (recombinant) | AIDS-related Kaposi's sarcoma | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | June 24, 1987 | |
Interferon alfa-2b (recombinant) | Chronic myeloid leukemia | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | June 22, 1987 | |
Interferon alfa-2b (recombinant) | Metastatic renal cell carcinoma | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | June 22, 1987 | |
Technetium Tc99m anti-melanoma murine monoclonal antibody | For use in detecting, by imaging, metastases of malignant melanoma | NeoRx Corporation;410 West Harrison;Seattle, Washington, 98119 | June 2, 1987 | |
Dalfampridine | Relief of symptoms of multiple sclerosis | Acorda Therapeutics;15 Skyline Dr.;Hawthorne, New York, 10532 | June 2, 1987 | |
Gonadorelin acetate | For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion | Ferring Laboratories, Inc.;400 Rella Boulevard, Suite 201;Suffern, New York, 10901 | April 22, 1987 |